The end of SAMHSA’s “waivered prescriber” MAT requirement: a grant writer’s farewell
Seliger + Associates Grant Writing
MARCH 1, 2023
”* Until this year, the Drug Enforcement Agency (DEA) required that doctors and nurse practitioners (NPs) / physicians assistants (PAs) who prescribe buprenorphine—the key medication used to treat persons with what SAMHSA and HRSA like to call “opioid use disorder” (OUD)—get a special DEA waiver.
40 
Let's personalize your content